(AMEM) MSCI Emerging Markets - Overview
Etf: Stocks, Emerging Markets, Equities, Index, ETF
| Risk 5d forecast | |
|---|---|
| Volatility | 14.1% |
| Relative Tail Risk | -3.41% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.09 |
| Alpha | 18.04 |
| Character TTM | |
|---|---|
| Beta | 0.223 |
| Beta Downside | 0.470 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.22% |
| CAGR/Max DD | 0.77 |
Description: AMEM MSCI Emerging Markets January 13, 2026
Amundi MSCI Emerging Markets UCITS (XETRA: AMEM) is a Germany-domiciled ETF that tracks the Morningstar Emerging Markets Total Market Index (TME) in net-return USD terms. It offers investors exposure to a broad basket of equities across 26 emerging economies, covering large-, mid- and small-cap stocks.
Key metrics (as of Q4 2025) include an expense ratio of 0.20 % and assets under management of roughly €7 billion, placing it among the larger EM equity ETFs. The fund’s top sector allocations are financials (≈ 22 %), technology (≈ 15 %) and consumer discretionary (≈ 13 %), reflecting the ongoing growth of digital finance and middle-class consumption in markets such as China, India and Brazil.
Recent macro drivers that have materially impacted performance are the tightening of global monetary policy-pressuring emerging-market currencies-and the rebound in commodity prices, which benefits resource-rich economies. Tracking error relative to the underlying index has averaged 0.12 % over the past 12 months, indicating tight replication.
For a deeper quantitative breakdown, you might explore ValueRay’s analytics platform to compare this ETF’s risk-adjusted returns against peers.
What is the price of AMEM shares?
Over the past week, the price has changed by +1.03%, over one month by +3.25%, over three months by +8.55% and over the past year by +25.33%.
Is AMEM a buy, sell or hold?
What are the forecasts/targets for the AMEM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 7.3 | 8.9% |
AMEM Fundamental Data Overview February 03, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.39b EUR (3.39b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 3.39b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.39b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.74% (E(3.39b)/V(3.39b) * Re(6.74%) + (debt-free company))
Discount Rate = 6.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)